Motlová Lucie Bankovská, Dragomirecká Eva, Matelová Sárka, Otevrelová Renata, Cermáková Radka, Cermák Jan, Lednická Eva, Hegedüsová Renata, Hübsch Tomás, Rothanzlová Sona, Tomesová Martina, Spaniel Filip, Kitzlerová Eva
Univerzita Karlova v Praze, 3. lékarská fakulta.
Cas Lek Cesk. 2010;149(1):21-5.
Antipsychotic medication and early relapse warning signs detection are the cornerstone of relapse prevention in schizophrenia spectrum disorders. Many patients do not use antipsychotic medication because of lack of information about its preventive effects and the risk of relapse. We introduce PREDUKA--PREventive EDUcational programme for relapse prevention. The goal of the programme is to deliver the information about schizophrenia to patients and their relatives. 178 patients and 252 relatives (118 mothers and 51 fathers) took part in 25 one-day psychoeducational programmes in 6 centres in the Czech Republic between January 2008 and June 2009 and anonymously fulfilled a short questionnaire. Patients and relatives assessed the programme with an average mark 1.4 (1 best, 5 worst). 49.4% patients and 49.0% relatives had received enough information about psychotic disorders during their hospitalization. Moreover 94.1% patients and 95.7% relatives confirmed acquiring new information on how to live with psychosis as a result of PREDUKA programme. 59.6% patients and 73.8% relatives were interested in ITAREPS - Information Technology Aided Relapse Prevention Programme. Mothers were significantly more interested (82.2%) than fathers (62.2%) (p = 0.031). Expressed high interest of patients and their relatives in both programmes indicates their readiness to become active and competent partners in the long-term treatment of schizophrenia spectrum disorders.
抗精神病药物治疗和早期复发预警信号检测是精神分裂症谱系障碍复发预防的基石。许多患者由于缺乏关于其预防作用和复发风险的信息而未使用抗精神病药物。我们推出了PREDUKA——预防复发教育项目。该项目的目标是向患者及其亲属提供有关精神分裂症的信息。2008年1月至2009年6月期间,178名患者和252名亲属(118名母亲和51名父亲)在捷克共和国的6个中心参加了25个为期一天的心理教育项目,并匿名填写了一份简短问卷。患者和亲属对该项目的平均评分是1.4(1为最佳,5为最差)。49.4%的患者和49.0%的亲属在住院期间获得了足够的关于精神障碍的信息。此外,94.1%的患者和95.7%的亲属确认由于PREDUKA项目获得了关于如何与精神病共存的新信息。59.6%的患者和73.8%的亲属对ITAREPS——信息技术辅助复发预防项目感兴趣。母亲的兴趣明显高于父亲(82.2%对62.2%)(p = 0.031)。患者及其亲属对这两个项目都表现出高度兴趣,表明他们愿意在精神分裂症谱系障碍的长期治疗中成为积极且有能力的伙伴。